NOVARTIS PHARMACEUTICALS CORPORATION v. BECERRA et al
Case Number:
3:23-cv-14221
Court:
Nature of Suit:
Judge:
Firms
- Akin Gump
- Buttaci Leardi
- Carella Byrne
- Flitter Milz
- Green Savits
- Latham & Watkins
- Motley Rice
- Weissman & Mintz
Companies
- AARP Inc.
- American College of Physicians
- American Public Health Association
- American Society of Hematology
- Center for American Progress
- Public Citizen Inc.
- UnidosUS
Government Agencies
Sectors & Industries:
-
March 12, 2025
Law360 Cheat Sheet: Novartis' Fight Over Generic Entresto
Novartis has led a wide-ranging litigation campaign to block generic versions of its bestselling cardiovascular drug Entresto that has involved multidistrict litigation, trips to several circuit courts and cases against the federal government. Here, Law360 breaks down how the various cases intersect and what's still playing out.
-
October 21, 2024
Novartis Loses Challenge To Medicare Drug Price Talks
A New Jersey federal judge on Friday tossed Novartis Pharmaceuticals' challenge to a Medicare drug price negotiation program, ruling the company is not required to participate, and that participating in the program does not violate its First Amendment rights.